LOADING
Comparing Broadcom Inc (AVGO) and AbbVie Inc (ABBV) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AVGO | ABBV |
|---|---|---|
| Price | $355.52 | $262.34 |
| Change Today | +3.46% | +0.93% |
| Market Cap | $1.68T | $459.3B |
| P/E Ratio | 45.3 | 74.0 |
| Forward P/E | 19.4 | 16.4 |
| PEG Ratio | 0.36 | 0.54 |
| EPS | $7.76 | $3.51 |
| Revenue Growth (YoY) | 85.5% | 10.2% |
| Profit Margin | 42.9% | 9.8% |
| Return on Equity | 44.3% | 62.3% |
| Dividend Yield | 0.73% | 2.61% |
| Beta | 1.46 | 0.28 |
| 52-Week High | $493.28 | $269.39 |
| 52-Week Low | $288.95 | $189.40 |
| Volume | 616K | 156K |
Broadcom Inc is the larger company by market capitalization. Broadcom Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.